Pulmatrix Stock Probability of Future Stock Price Finishing Under 2.28
| PULM Stock | USD 6.00 0.09 1.52% |
Pulmatrix |
Pulmatrix Target Price Odds to finish below 2.28
The tendency of Pulmatrix Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 2.28 or more in 90 days |
| 6.00 | 90 days | 2.28 | about 23.7 |
Based on a normal probability distribution, the odds of Pulmatrix to drop to $ 2.28 or more in 90 days from now is about 23.7 (This Pulmatrix probability density function shows the probability of Pulmatrix Stock to fall within a particular range of prices over 90 days) . Probability of Pulmatrix price to stay between $ 2.28 and its current price of $6.0 at the end of the 90-day period is about 64.42 .
Given the investment horizon of 90 days Pulmatrix has a beta of -0.69 indicating as returns on the benchmark increase, returns on holding Pulmatrix are expected to decrease at a much lower rate. During a bear market, however, Pulmatrix is likely to outperform the market. In addition to that Pulmatrix has an alpha of 2.0613, implying that it can generate a 2.06 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Pulmatrix Price Density |
| Price |
Predictive Modules for Pulmatrix
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pulmatrix. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pulmatrix Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pulmatrix is not an exception. The market had few large corrections towards the Pulmatrix's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pulmatrix, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pulmatrix within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.06 | |
β | Beta against Dow Jones | -0.69 | |
σ | Overall volatility | 1.96 | |
Ir | Information ratio | 0.17 |
Pulmatrix Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pulmatrix for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pulmatrix can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pulmatrix is way too risky over 90 days horizon | |
| Pulmatrix appears to be risky and price may revert if volatility continues | |
| Pulmatrix has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 7.3 M. Net Loss for the year was (14.12 M) with profit before overhead, payroll, taxes, and interest of 6.07 M. | |
| Pulmatrix currently holds about 42.91 M in cash with (15.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.67, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Pulmatrix has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Pulmatrix secures director positions and ratifies accounting firm |
Pulmatrix Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pulmatrix Stock often depends not only on the future outlook of the current and potential Pulmatrix's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pulmatrix's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.7 M | |
| Cash And Short Term Investments | 19.2 M |
Pulmatrix Technical Analysis
Pulmatrix's future price can be derived by breaking down and analyzing its technical indicators over time. Pulmatrix Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pulmatrix. In general, you should focus on analyzing Pulmatrix Stock price patterns and their correlations with different microeconomic environments and drivers.
Pulmatrix Predictive Forecast Models
Pulmatrix's time-series forecasting models is one of many Pulmatrix's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pulmatrix's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Pulmatrix
Checking the ongoing alerts about Pulmatrix for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pulmatrix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pulmatrix is way too risky over 90 days horizon | |
| Pulmatrix appears to be risky and price may revert if volatility continues | |
| Pulmatrix has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 7.3 M. Net Loss for the year was (14.12 M) with profit before overhead, payroll, taxes, and interest of 6.07 M. | |
| Pulmatrix currently holds about 42.91 M in cash with (15.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.67, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Pulmatrix has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Pulmatrix secures director positions and ratifies accounting firm |
Check out Pulmatrix Backtesting, Pulmatrix Valuation, Pulmatrix Correlation, Pulmatrix Hype Analysis, Pulmatrix Volatility, Pulmatrix History as well as Pulmatrix Performance. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.64) | Revenue Per Share 3.119 | Quarterly Revenue Growth (0.16) | Return On Assets (0.30) | Return On Equity (0.59) |
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.